JCR Pharmaceuticals Co (TSE:4552) Construction In Progress : 円121 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co Construction In Progress?

JCR Pharmaceuticals Co's quarterly construction in progress declined from Jun. 2023 (円13,246 Mil) to Sep. 2023 (円144 Mil) and declined from Sep. 2023 (円144 Mil) to Dec. 2023 (円121 Mil).

JCR Pharmaceuticals Co's annual construction in progress increased from Mar. 2022 (円8,019 Mil) to Mar. 2023 (円13,008 Mil) but then declined from Mar. 2023 (円13,008 Mil) to Mar. 2024 (円0 Mil).

JCR Pharmaceuticals Co Construction In Progress Historical Data

The historical data trend for JCR Pharmaceuticals Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCR Pharmaceuticals Co Construction In Progress Chart

JCR Pharmaceuticals Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Construction In Progress

Get a 7-Day Free Trial

2,283.00

841.00

8,019.00

13,008.00

JCR Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															13,008.00	13,246.00	144.00	121.00	-

JCR Pharmaceuticals Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

JCR Pharmaceuticals Co (TSE:4552) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

JCRRF:USA

Address

3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021

Website

http://www.jcrpharm.co.jp

JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co (TSE:4552) Headlines

No Headlines